An in-depth analysis of the $300B Oracle-OpenAI cloud computing deal, updated through April 2026. Covers the operational Abilene flagship, $122B OpenAI funding round, Oracle's $523B backlog, Stargate expansion to 7 GW, and IPO preparations.
An in-depth analysis of the leaders in pharma digital transformation, examining the strategies of companies like AstraZeneca, Roche, Pfizer, Eli Lilly, and Sanofi with AI, generative AI, and cloud technologies — updated with 2025-2026 developments including Lilly's $1B NVIDIA AI lab and FDA AI guidance.
Updated for 2026, this article profiles five leading technology companies in healthcare AI—IntuitionLabs, AWS, Google Cloud, IBM, and Microsoft—examining their latest solutions for clinical workflows, AI agents, and patient engagement.
Explore AWS cloud computing's role in life sciences for scalable data processing, HPC, and analytics. Learn how AWS facilitates innovation in biotech and pharma.
An in-depth comparison of cloud-based and on-premise Randomization and Trial Supply Management (RTSM) solutions, analyzing security, compliance, cost, and operational considerations for pharmaceutical companies.
A comprehensive guide to how Amazon Web Services (AWS) is transforming pharmaceutical operations from drug discovery to manufacturing, with real-world case studies from Pfizer, Moderna, Merck, and more.
A comprehensive analysis of how Google Cloud Platform (GCP) is revolutionizing pharmaceutical operations, from AI-powered drug discovery to clinical trial management and regulatory compliance.
An in-depth analysis of IBM's contributions to pharmaceutical innovation, from AI-powered drug discovery and hybrid cloud infrastructure to regulatory compliance and security solutions.
An in-depth exploration of how pharmaceutical companies leverage Microsoft Azure's cloud platform for drug discovery, clinical trials, manufacturing, and regulatory compliance, with real-world case studies and implementation strategies.
An in-depth guide to designing and implementing modern datacenter infrastructure for pharmaceutical companies, focusing on scalability, security, regulatory compliance, and integration with cloud services for drug development and manufacturing.
Comprehensive overview of Oracle's role in the pharmaceutical industry, covering their Health Sciences solutions, cloud infrastructure, compliance features, and case studies of successful implementations at major pharma companies.
A comprehensive analysis of cloud computing adoption versus traditional on-premises infrastructure in the pharmaceutical industry, including current adoption rates, historical trends, future forecasts, and key drivers of cloud migration.
© 2026 IntuitionLabs. All rights reserved.
